Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients.

Oncology reports - 1 Sept 2013

Lewandowska Marzena Anna, Jóźwicki Wojciech, Jochymski Cezary, Kowalewski Janusz

Abstract excerpt

The epidermal growth factor receptor (EGFR) mutation status in the tyrosine kinase domain is known to be a predictor of the response to gefitinib or erlotinib in lung cancer; thus, a non-surgical procedure of tumor specimen collection is critical for mutation analysis. The aim of the present study was to analyze the EGFR, KRAS and BRAF status in limited cytological material. To the best of our knowledge, this is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Biopsy, Fine-Needle

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytodiagnosis

Share to DNA, Neoplasm

Share to Proto-Oncogene Proteins B-raf

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Share to Real-Time Polymerase Chain Reaction

Source

Open in PubMed Open full text

Identifiers

PMID: 23817662
DOI: 10.3892/or.2013.2579
PMCID: PMC3783057

Genes

EGFR
KRAS
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of PCR methods to evaluate EGFR, KRAS and BRAF mutations in a small number of tumor cells in cytological material from lung cancer patients.PMID 23817662Read ↗

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.Semantic proximity Read ↗

Use of Exfoliative Specimens and Fine-Needle Aspiration Smears for Mutation Testing in Lung Adenocarcinoma.Semantic proximity Read ↗

Importance of the cytological samples for the epidermal growth factor receptor gene mutation test for non-small cell lung cancer.Semantic proximity Read ↗

[Detection of EGFR and K-ras mutations in non-small cell lung cancer using cytological specimens].Semantic proximity Read ↗

Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.Semantic proximity Read ↗

Detection of epidermal growth factor receptor mutations in a few cancer cells from transbronchial cytologic specimens by reverse transcriptase-polymerase chain reaction.Semantic proximity Read ↗

Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates.Semantic proximity Read ↗

Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.Semantic proximity Read ↗

Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.Semantic proximity Read ↗

EGFR analysis: current evidence and future directions.Semantic proximity Read ↗

EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.